| abstract |
The present invention relates to a pharmaceutical composition comprising, (i) a cytokine and, (ii) a compound of the general formula (Qi) or pharmaceutically acceptable salts thereof with an acid or a base, or pharmaceutically acceptable prodrugs or a stereoisomer thereof. Exemplary cytokines are selected from the following group of cytokine families, (i) the four α-helix bundle family, which consists of, (a) the the IL-2 subfamily, (b) the interferon (IFN) subfamily and, (c) the IL-IO subfamily, (ii) the IL-I family, (iii) the IL- 17 family and, (iv) chemokines. |